New COPD inhaler put to the test in Year-Long safety study
NCT ID NCT07425210
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the long-term safety of an experimental inhaler called HSK39004 for people with moderate-to-severe chronic obstructive pulmonary disease (COPD). About 300 adults aged 40 to 80 will use the inhaler twice daily for 52 weeks. Researchers will monitor side effects and overall health to see if the treatment is safe to use over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE LUNG DISEASE (COLD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guizhou Provincial People's Hospital
Guiyang, Guizhou, 550002, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.